Our results show that LAG-3 and PD-1 may be involved in the changes of CD4+/CD8+ cell balance in patients with DLBCL, which may be caused by down-regulation of the T cell immune response, influencing T cell immune response balance, and inhibiting immune responses, thereby inducing tumor cell immune evasion. The gene discussed is LAG3; the disease is neoplasm.